İsMet Bilger Erihan

İsMet Bilger Erihan

Auto-generated profile, based on publicly available information

İsMet Bilger Erihan

Kafkas University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2022 in Andrologia
Verified
Journal Article
Closed access
ÜYümit Yıldırım
ümit Yıldırım
MKMuammer Karakayalı
Muammer Karakayalı
MUMehmet Uslu
Mehmet Uslu
MEMehmet Ezer
Mehmet Ezer
IEIsmet Bilger Erihan
Ismet Bilger Erihan
IRIbrahim Rencüzoğulları
Ibrahim Rencüzoğulları
By the beginning of this study in 2019, it was known that hypertension is a risk factor for erectile dysfunction, and also, there are circadian changes that occur in blood pressure. Further, non-dipping hypertension is known to be linked to poor cardiac outcomes and erectile functions, so the research described in this article was initiated with an aim to explore the potential relationship between erectile dysfunction and circadian patterns of newly diagnosed hypertension. Between April 2019 and May 2022, 583 patients aged 30-70 years were diagnosed with erectile dysfunction (ED) in our outpatient clinic. Applying our exclusion criteria to 583 patients, a group of 371 patients left with us; these patients were referred to the cardiology clinic for hypertension evaluation with consecutive ambulatory blood pressure monitoring (ABPM). Data were collected for the study prospectively. Of the 371 patients evaluated with ABPM, 125 had newly diagnosed hypertension (mean BP ≥135/85 mmHg in ABPM). These patients were divided into two groups according to the pattern of hypertension identified in ABPM: dippers (Group D) and non-dippers (Group ND). They were then compared using clinical and laboratory findings, including erectile function scores. While the number of patients in the ND group was 83, the number in the D group was 42. In the ND group, the mean age was higher (59 ± 10 vs. 54 ± 12, p = 0.0024). IIEF-5 (international index of erectile function) scores were determined to be significantly lower in the ND group (14.4 ± 4.9 vs. 11.5 ± 4.6, p = 0.001). Also, serum creatinine levels were higher in Group ND than in D (0.96 ± 0.12 vs. 1 ± 0.15, p = 0.001). In our multivariate analysis, IIEF-5 scores (OR: 0.880, 95% CI: 0.811-0.955; p = 0.002) and serum creatinine levels (OR: 1027, 95% CI: 1003-1052; p = 0.025) were found to be independent risk factors of non-dipper HT. The cut-off value of the IIEF-5 score for non-dipper HT in a ROC curve analysis was 13.5 with 64.3% sensitivity and 66.1% specificity (area under curve value: 0.673 [95% CI: 0.573-0.772, p < 0.001]). This study showed that, in patients with ED, the non-dipper pattern was associated with poorer erectile function when HT was newly diagnosed. We also found that the severity of erectile dysfunction is an independent marker for non-dipper HT.

3 October 2019 in European Urology Supplements
Verified
Journal Article
Closed access
MKM.A. Karagöz
M.A. Karagöz
IEİ.B. Erihan
İ.B. Erihan
ÖDÖ.G. Doluoğlu
Ö.G. Doluoğlu
ÇUÇ. Uğurlu
Ç. Uğurlu
MBM. Bağcıoğlu
M. Bağcıoğlu
KSKemal Sarıca
Kemal Sarıca

26 December 2025
Verified
Book
Closed access
GÖGülüzar Özbolat
Gülüzar Özbolat
ÖTÖzge Nur Türkeri
Özge Nur Türkeri
MSMurat Serilmez
Murat Serilmez
UGUgur Gezer
Ugur Gezer
EOEmre Ozgur
Emre Ozgur
AHAhmet Harmankaya
Ahmet Harmankaya
Belçika'da doğdu. İlkokulu Belçika'nın Anvers kentinde tamamladı. 2002 yılında Hacettepe Üniversitesi Fen Fakültesi %100 İngilizce-Kimya Bölümünden mezun oldu. 2002 yılında akademik kariyerine Araştırma Görevlisi olarak Sivas Cumhuriyet Üniversitesinde başladı. 2005 yılında Yüksek Lisansını ve 2009 yılında Doktora programını Hacettepe Üniversitesi ve Cumhuriyet Üniversitesi ortak Biyokimya programında tamamladı. 2002 yılında başladığı akademik hayatına, 2010 yılından itibaren Cumhuriyet Üniversitesi Fen Fakültesi Moleküler Biyoloji ve Genetik Bölümünde Öğretim Üyesi olarak devam etmektedir. 2016-2017 yılları arasında doktora sonrası araştırma yapmak için TÜBİTAK bursu ile Cleveland/Ohio Amerikada, Case Western Reserve Üniversitesinde çalışmalar yaptı. Burada yapmış olduğu çalışmalarından dolayı Uluslararası Ödüle layık görüldü. Bölüm Başkanlığı, Bilimsel Araştırma Projeleri komisyon üyeliği, Fakülte kurulu üyeliği gibi idari görevlerde bulunmuştur. Avrupa Birliği Cost Aksiyon projesinde araştırma grubuna seçilerek Cost üyesi olarak görev yapmaktadır. Avrupa Birliği ajansında bağımsız dış uzman olarak uzun yıllardır görev yapmaktadır. Başta TÜBİTAK destekli olmak üzere 20 civarı projede görev almış ve tamamlamıştır. Yaklaşık 77 civarı yayını olan Prof. Dr. Birnur AKKAYA, çeşitli bilimsel ve mesleki dergilerde Editör ve hakem olarak görev almaktadır. Kanser türü hastalıkları önlemeye yönelik çalışmasından dolayı, Türk Marka ve Patent Kurumundan Patent almıştır. Bilim Kadınları Derneğinin kurucu başkanı ve hala yönetim kurulu başkanıdır. 2025 YÖK Bilim Diplomasisi üstün başarı ödülüne layık görülmüştür. Akademik akıl köşe yazarıdır. İngilizce ve Flamanca bildiği diller arasındadır. Evli ve üç erkek çocuk sahibidir.

27 December 2025 in BMC Urology
Verified
Journal Article
Open access
PDF file
ÜYümit Yıldırım
ümit Yıldırım
MUMehmet Uslu
Mehmet Uslu
MEMehmet Ezer
Mehmet Ezer
IEİsMet Bilger Erihan
İsMet Bilger Erihan
AÇAbdullah Çayirli
Abdullah Çayirli
RKRamazan Kocaaslan
Ramazan Kocaaslan
To explore the possible impact of real-time ultrasound screen visualization on pain perception, anxiety levels, and overall patient experience during trans

23 September 2026 in Laboratuvar Hayvanları Bilimi ve Uygulamaları Dergisi
Verified
Journal Article
Open access
SKSelina Aksak Karameşe
Selina Aksak Karameşe
MEMehmet Ezer
Mehmet Ezer
IEİsMet Bilger Erihan
İsMet Bilger Erihan
BÖBengül Özdemir
Bengül Özdemir
This study evaluated and compared the protective effects of umbelliferone and naringin, each administered at two dose levels (50 and 100 mg/kg), against torsion/detorsion (T/D)-induced testicular injury in a rat model. Forty-two adult male Sprague-Dawley rats were randomly allocated into seven groups (n=6 each): control, Sham, T/D, and T/D treated with umbelliferone (50 and 100 mg/kg) or naringin (50 and 100 mg/kg) for seven consecutive days after torsion. Left testicular torsion was induced (720°, 2 h ischemia) followed by a 7-day reperfusion. Testicular histology (H&E), NF-κB immunohistochemistry, and serum ELISA levels of TNF-α, IL-1β, IL-8, StAR, 3β-HSD, and 17β-HSD were assessed. T/D produced marked seminiferous tubule disorganization, degenerated spermatids, and increased NF-κB immunopositivity compared with controls. T/D also significantly elevated TNF-α, IL-1β, and IL-8 and suppressed StAR, 3β-HSD, and 17β-HSD levels relative to control. Both umbelliferone and naringin, at either dose, preserved seminiferous tubule structure, reduced NF-κB immunoreactivity, and significantly lowered all three pro-inflammatory cytokines compared with the T/D group. 17β-HSD levels were significantly restored by both compounds at both doses, with a parallel, though not statistically significant, trend toward restoration observed for 3β-HSD and StAR. Umbelliferone and naringin confer comparable, meaningful protection against T/D-induced testicular injury by attenuating NF-κB activation, pro-inflammatory cytokine release, and steroidogenic enzyme suppression, supporting their potential as protective agents against testicular ischemia-reperfusion injury.

20 October 2025 in The New Journal of Urology
Verified
Journal Article
Open access
ÜYümit Yıldırım
ümit Yıldırım
MUMehmet Uslu
Mehmet Uslu
MEMehmet Ezer
Mehmet Ezer
IEİsMet Bilger Erihan
İsMet Bilger Erihan
AKAli Alper Kahraman
Ali Alper Kahraman
Objective: The purpose of this study is to examine how acute ischemia-reperfusion injury (IRI) in a rat model is affected by replacing human serum albumin (HSA). Material and Methods: Thirty-six male Wistar albino rats were randomly divided into six groups: Control, Ischemia, Ischemia-Reperfusion (IR), Placebo, Preoperative Albumin (A1), and Intraoperative Albumin (A2). The renal artery of the kidney was blocked using 3/0 silk sutures to induce ischemia, followed by one hour of reperfusion in certain groups. The A1 group received 20% HSA (2.5 g/kg intraperitoneally) 24 hours before surgery, while the A2 group received the same dose 30 minutes before reperfusion. Samples of kidney and blood tissue were gathered for immunohistochemical, histological, and biochemical assessments. Biochemical parameters included ischemia-modified albumin (IMA), total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI). Histological assessments measured cortical and medullary damage, while immunohistochemistry evaluated oxidative stress markers such as superoxide dismutase (SOD1), glutathione reductase (GSR), and myeloperoxidase (MPO). Results: Biochemical analyses showed no significant differences in TOS, TAS, OSI, and IMA levels between groups. Histological evaluation revealed that the A2 group had reduced kidney damage, particularly in the medulla, compared to the ischemia and placebo groups. Immunohistochemical findings indicated minor differences in oxidative stress marker expression, though not statistically significant. Conclusion: Intraoperative HSA replacement has the potential to reduce ischemia-induced renal injury in rats, especially in medullary tissues. These findings suggest that HSA may be a promising therapeutic agent for managing ischemic kidney damage during partial nephrectomy. Further clinical studies are needed to validate its efficacy and safety in human applications.